Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature

Different monoclonal antibodies have been used for the treatment of Netherton’s syndrome (NS); secukinumab (anti-IL17A), infliximab (anti-TNF-α), ustekinumab (anti p40 subunit of IL-12 and IL-23), omalizumab (anti-IgE), and dupilumab (anti-IL4 and IL13). We report two sisters with severe NS who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-García, Cristina, Godoy, Elena, Cabrera, Adelaida, Cañueto, Javier, Muñoz-Bellido, Francisco J, Perez-Pazos, Jacqueline, Dávila, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201149/
https://www.ncbi.nlm.nih.gov/pubmed/37200480
http://dx.doi.org/10.1177/03946320231172881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201149/
https://www.ncbi.nlm.nih.gov/pubmed/37200480
http://dx.doi.org/10.1177/03946320231172881

Ejemplares similares